BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27008430)

  • 1. The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy.
    Wakatsuki M; Kato S; Kiyohara H; Ohno T; Karasawa K; Tamaki T; Ando K; Shiba S; Kamada T; Nakano T
    BMC Cancer; 2016 Mar; 16():244. PubMed ID: 27008430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy for stage IVA cervical cancer.
    Murakami N; Kasamatsu T; Morota M; Sumi M; Inaba K; Ito Y; Itami J
    Anticancer Res; 2013 Nov; 33(11):4989-94. PubMed ID: 24222140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
    Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
    Gynecol Oncol; 2011 Jun; 121(3):542-5. PubMed ID: 21420157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
    Tan LT; Jones B; Gee A; Kingston RE
    Br J Radiol; 1997 Dec; 70(840):1259-69. PubMed ID: 9505845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose-rate interstitial computed tomography-based brachytherapy for the treatment of cervical cancer: early results.
    Kannan N; Beriwal S; Kim H; Houser C; Mogus R; Sukumvanich P; Olawaiye AB; Richard S; Kelley JL; Edwards RP; Krivak TC
    Brachytherapy; 2012; 11(5):408-12. PubMed ID: 22513106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-room computed tomography-based brachytherapy for uterine cervical cancer: results of a 5-year retrospective study.
    Ohno T; Noda SE; Okonogi N; Murata K; Shibuya K; Kiyohara H; Tamaki T; Ando K; Oike T; Ohkubo Y; Wakatsuki M; Saitoh JI; Nakano T
    J Radiat Res; 2017 Jul; 58(4):543-551. PubMed ID: 27986859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancer.
    Kim KH; Kim S; Kim GE; Koom WS; Kim SW; Nam EJ; Suh CO; Kim YB
    Gynecol Oncol; 2015 Dec; 139(3):439-46. PubMed ID: 26456139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitive radiation therapy in the treatment of carcinoma of the uterine cervix. Treatment results and prognostic factors.
    Busch M; Dühmke E; Kuhn W; Teichmann A
    Strahlenther Onkol; 1991 Nov; 167(11):628-37. PubMed ID: 1962276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate intra-cavitary brachytherapy combined with external beam radiation therapy for under 40-year-old patients with invasive uterine cervical carcinoma: clinical outcomes in 118 Patients in a Japanese multi-institutional study, JASTRO.
    Yamashita H; Niibe Y; Toita T; Kazumoto T; Nishimura T; Kodaira T; Eto H; Kinoshita R; Tsujino K; Onishi H; Takemoto M; Hayakawa K
    Jpn J Clin Oncol; 2013 May; 43(5):547-52. PubMed ID: 23475536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of MRI-detected bladder muscle and/or serosal invasion in patients with cervical cancer treated with radiotherapy.
    Nam H; Huh SJ; Park W; Bae DS; Kim BG; Lee JH; Kim CK; Park BK
    Br J Radiol; 2010 Oct; 83(994):868-73. PubMed ID: 20846984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.
    Kaneyasu Y; Kita M; Okawa T; Maebayashi K; Kohno M; Sonoda T; Hirabayashi H; Nagata Y; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):137-45. PubMed ID: 22285665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis: are all patients with stage II disease suitable candidates for chemoradiotherapy?
    Kodaira T; Fuwa N; Kamata M; Furutani K; Kuzuya K; Ogawa K; Toita T; Sasaoka M; Nomoto Y
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):627-36. PubMed ID: 11849783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy.
    Kodaira T; Fuwa N; Toita T; Nomoto Y; Kuzuya K; Tachibana H; Furutani K; Ogawa K
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):769-77. PubMed ID: 12788184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement.
    Sammouri J; Venkatesan AM; Lin LL; Jhingran A; Klopp AH; Joyner MM; Eifel PJ; Colbert LE
    Gynecol Oncol; 2024 Jan; 180():24-34. PubMed ID: 38041900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.